deciding on rituximab versus obinutuzumab in follicular lymphoma
Published 4 years ago • 979 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
4:38
an in-depth look at treatment of follicular lymphoma
-
5:17
follicular lymphoma: selecting frontline therapy
-
3:18
obinutuzumab & rituximab safety risks
-
4:21
deciding on therapy for follicular lymphoma
-
4:34
obinutuzumab bests rituximab for pfs in follicular lymphoma
-
4:53
maintenance therapy in follicular lymphoma
-
2:45
follicular lymphoma: selecting upfront therapy
-
8:30
gallium trial: follicular lymphoma
-
3:04
maintenance therapy for patients with follicular lymphoma
-
12:52
debate: is obinutuzumab superior to rituximab in lymphoma? - yes
-
3:57
follicular lymphoma: initiating treatment
-
14:02
debate: is obinutuzumab superior to rituximab in lymphoma? - no
-
10:27
treatment approach in follicular lymphoma
-
6:53
risk assessment for follicular lymphoma
-
2:53
follicular lymphoma: obinutuzumab and chemotherapy
-
1:18
findings from the relevance trial in follicular lymphoma
-
1:17
dr. grossbard on the role of maintenance rituximab in follicular lymphoma
-
9:22
follicular lymphoma: novel approaches with rituximab
-
6:30
fl: switching to bendamustine/rituximab at progression